Dose Attenuated Chemotherapy in Compromised Patients With Lung Cancer

Dose Attenuated Chemotherapy in Compromised Patients With Lung Cancer

Drug: Carboplatin

Standard of care chemotherapy regimen

Drug: Pemetrexed

Standard of care chemotherapy regimen

Drug: Paclitaxel

Standard of care chemotherapy regimen

Drug: Nab paclitaxel

Standard of care chemotherapy regimen

Drug: Docetaxel

Standard of care chemotherapy regimen

Drug: Gemcitabine

Standard of care chemotherapy regimen

Drug: Etoposide

Standard of care chemotherapy regimen

Drug: Irinotecan

Standard of care chemotherapy regimen

Drug: Topotecan

Standard of care chemotherapy regimen

Drug: Lurbinectedin

Standard of care chemotherapy regimen

Source: View full study details on ClinicalTrials.gov

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. By listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.

April 15, 2023Comments OffClinicalTrials.gov | Oncology Clinical Trials | Oncology Studies | US National Library of Medicine
Comments